Bio-Path Holdings Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Bio-Path Holdings

Access the complete profile.

Bio-Path Holdings Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	Suite 210 4710, Bellaire Boulevard Bellaire, TX 77401

Note: Revenues for privately held companies are statistical evaluations.


Bio-Path Holdings's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Bio-Path Holdings's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Bio-Path Holdings is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Bio-Path Holdings Annual Revenue and Growth Rate

Bio-Path Holdings	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Bio-Path Holdings's revenues are gauged from an analysis of company filings.

Bio-Path Holdings's Income Statement (based on Industry Averages)

Bio-Path Holdings P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Bio-Path Holdings is developing and marketing. Bio-Path Holdings doesn't have any recent trademark applications, indicating Bio-Path Holdings is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DNABILIZE Pharmaceutical preparations containing liposomes for use as drug delivery agents that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of liposomes that facilitate the delivery of pharmaceutical preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals	05/05/2015

See all trademarks and details in the Full Report.

Market Share of Bio-Path Holdings's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bio-Path Holdings, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Bio-Path Holdings. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GEOMARK RESEARCH	Cypress, TX	100
ADVANCED POWDER SOLUTIONS	Cypress, TX	88
HOPE BIOSCIENCES	Sugar Land, TX	88
SHEFFIELD SCIENTIFIC	Katy, TX	73
YOKOGAWA FLUENCE ANALYTICS	Stafford, TX	71
SYNERGY GROUPS MEDICAL LLC.	Richmond, TX	53

Future Competition: Bio-Path Holdings's Fastest Growing Competitors

These companies are in the same general field as Bio-Path Holdings and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)